Medical Research News

RSS

Monoclonal antibody neutralizes all SARS-CoV-2 variants of concern

Researchers in Canada and the United States have identified a monoclonal antibody that potently neutralizes variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the ongoing coronavirus disease 2019 (COVIdD-19) pandemic.

3 May 2021

Researchers demonstrate real-world effectiveness of Johnson & Johnson COVID-19 vaccine

Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson & Johnson’s Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).

3 May 2021

College athletes in a supportive environment coped better during the COVID-19 pandemic

Like much of society, college athletics were thrown into disarray by the COVID-19 pandemic. While student athletes were suddenly prevented from competing, training or seeing as much of their teammates and coaches, those who perceived they were part of a positive sporting environment also coped better during the early days of the crisis, a new study from the University of Kansas has found.

3 May 2021

Deworming treatment during pregnancy reduces risk of neonatal mortality and low birthweight

More than 25% of the world's population (greater than 1.5 billion people) face the burden of soil-transmitted helminth (STH) infections, a species of intestinal parasite whose eggs develop in the soil before finding a new host.

3 May 2021

Study provides the most comprehensive look yet on COVID-19 hospital mortality

A new study of hospital deaths in the United States, published today in JAMA Network Open, is the most comprehensive look yet at changes in hospital mortality during the pandemic.

3 May 2021

New study launched to more accurately diagnose early hepatocellular carcinoma

A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual's likelihood of developing the cancer.

3 May 2021

IBEC researchers discover the neural mechanism of autonomous learning

Thanks to the so-called deep learning, a subset of artificial intelligence (AI) algorithms inspired by the brain, machines can match human performance in perception and language recognition and even outperform humans in certain tasks. But do these synthetic biologically inspired systems learn in the same way that we do?

3 May 2021

Health anxiety in childhood and adolescence can become a permanent problem

Symptoms of health anxiety are common already during childhood and adolescence - and if the children do not receive the correct help, the anxiety can become a permanent problem with serious personal and socio-economic consequences.

3 May 2021

Simple application of UVC light could make common disinfectants safer to use

Over 400 common disinfectants currently in use could be made safer for people and the environment and could better fight the COVID-19 virus with the simple application of UVC light, a new study from the University of Waterloo shows.

3 May 2021

New findings on the support and barriers to combat TB in high-burden countries

Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme.

3 May 2021

Study highlights the importance of improving real and perceived motor competence in children

he AIFPS (Physical Activity and Health Promotion) research group of the University of Valencia has carried out a study that has made it possible to develop longitudinal profiles based on real and perceived motor competence (MC), and the physical condition of boys and girls aged 4 to 9.

3 May 2021

Low doses of ionizing radiation may be a promising therapy for people with Alzheimer’s disease

Individuals living with severe Alzheimer's disease showed remarkable improvements in behavior and cognition within days of receiving an innovative new treatment that delivered low doses of radiation, a recent Baycrest-Sunnybrook pilot study found.

3 May 2021

Review outlines ways to effectively deliver radiotherapy to optimize benefit and minimize risk

A comprehensive review by University of North Carolina researchers and colleagues highlights the optimal ways that focused, high-dose radiation can be delivered to various types of tumors while sparing normal tissue and mitigating long-term side effects.

3 May 2021

NSAIDs could help mitigate the short-term impacts of air pollution on cognition

Exposure to air pollution, even over the course of just a few weeks, can impede mental performance, according to a new study led by researchers at Columbia University Mailman School of Public Health.

3 May 2021

Social cognition may exert a central role in the daily lives of MS patients

An international team of multiple sclerosis (MS) researchers showed that longitudinal changes in social cognition are associated with psychological outcomes of daily living, suggesting that social cognition may exert a central role in people with MS.

3 May 2021

Disparities exist in colorectal cancer screenings, study finds

Patients with one or more health conditions are more likely to be screened for colorectal cancer than those without comorbidities, according to new research in the Journal of Osteopathic Medicine.

3 May 2021

Glandular fever associated with greater risk of depression

New research shows that patients who have had contact with the hospital due to serious glandular disease have a greater risk of subsequently developing depression.

3 May 2021

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

3 May 2021

SARS-CoV-2 antibodies are detectable up to a year after infection, finds study

A team of scientists from the United States has recently investigated the robustness and durability of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in coronavirus disease 2019 (COVID-19) patients. Their findings reveal that COVID-19 patients exhibit a strong anti-SARS-CoV-2 antibody response for up to 1 year and that the robustness of antibody response depends on the patient’s age and disease severity.

3 May 2021

SARS-CoV-2 spike mutations during transmission among humans and to animals

A fascinating new study discusses the 40 mutations that are seen on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and their potential effects on viral biology.

3 May 2021